Axial spondyloarthritis: emerging drug targets - Université de Versailles Saint-Quentin-en-Yvelines
Journal Articles Expert Opinion on Therapeutic Targets Year : 2021

Axial spondyloarthritis: emerging drug targets

Domains

Health

Équipe HAL UVSQ  : Connect in order to contact the contributor

https://hal.uvsq.fr/hal-04534052

Submitted on : Friday, April 5, 2024-11:43:16 AM

Last modification on : Sunday, April 7, 2024-3:11:03 AM

No file

Dates and versions

hal-04534052 , version 1 (05-04-2024)

Identifiers

Cite

Bilade Cherqaoui, Luiza Araujo, Simon Glatigny, Maxime Breban. Axial spondyloarthritis: emerging drug targets. Expert Opinion on Therapeutic Targets, 2021, 25 (8), pp.633-644. ⟨10.1080/14728222.2021.1973429⟩. ⟨hal-04534052⟩

Export

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

UVSQ UNIV-PARIS-SACLAY 2IC GS-HEALTH-DRUG-SCIENCES
7 View
0 Download

Altmetric

Share

More